Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 226 AL 240

The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics

Mullane K, Williams M.

Curr Opin Pharmacol. 2019 Feb;44:62-75. doi: 10.1016/j.coph.2019.01.004. Epub 2019 Feb 19.

Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease

Gupta J, Fatima MT, Islam Z, Khan RH, Uversky VN, Salahuddin P.

Int J Biol Macromol. 2019 Jun 1;130:515-526. doi: 10.1016/j.ijbiomac.2019.02.156. Epub 2019 Feb 28.

Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia

Vaquero J, Zurita M, Mucientes J, Pascual ML, Fernández-Mateos C, Garcia E, Fernández-Guinea S.

Cytotherapy. 2019 Apr;21(4):428-432. doi: 10.1016/j.jcyt.2019.02.009. Epub 2019 Mar 14.

[Pharmaceutical care for patients and their caregivers in Alzheimer's disease and related disorders: a review and new perspectives]

Novais T, Mouchoux C.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Mar 1;17(1):7-19. doi: 10.1684/pnv.2018.0767.

Therapeutic Role of Transcranial Direct Current Stimulation in Alzheimer Disease Patients: Double-Blind, Placebo-Controlled Clinical Trial

Khedr EM, Salama RH, Abdel Hameed M, Abo Elfetoh N, Seif P.

Neurorehabil Neural Repair. 2019 May;33(5):384-394. doi: 10.1177/1545968319840285. Epub 2019 Apr 3.

Carbon nanomaterials and amyloid-beta interactions: potentials for the detection and treatment of Alzheimer's disease?

Mohajeri M, Behnam B, Barreto GE, Sahebkar A.

Pharmacol Res. 2019 May;143:186-203. doi: 10.1016/j.phrs.2019.03.023. Epub 2019 Mar 31.

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P.

Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x.

D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia

Goetghebeur PJD, Wesnes KA, Targum SD.

J Alzheimers Dis. 2019;69(2):377-383. doi: 10.3233/JAD-181094.

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study

Jernerén F, Cederholm T, Refsum H, Smith AD, Turner C, Palmblad J, Eriksdotter M, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Freund-Levi Y.

J Alzheimers Dis. 2019;69(1):189-197. doi: 10.3233/JAD-181148.

Errorless Learning as a method of neuropsychological rehabilitation of individuals suffering from dementia in the course of Alzheimer's disease

Śmigórska A, Śmigórski K, Rymaszewska J.

Psychiatr Pol. 2019 Feb 28;53(1):117-127. doi: 10.12740/PP/81104. Epub 2019 Feb 28.

Editorial

Kasper S.

World J Biol Psychiatry. 2019 Mar;20(3):169-170. doi: 10.1080/15622975.2019.1589053.

Treatment Effects of Vortioxetine on Cognitive Functions in Mild Alzheimer's Disease Patients with Depressive Symptoms: A 12 Month, Open-Label, Observational Study

Cumbo E, Cumbo S, Torregrossa S, Migliore D.

J Prev Alzheimers Dis. 2019;6(3):192-197. doi: 10.14283/jpad.2019.24.

Depression in Alzheimer's Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?

Elsworthy RJ, Aldred S.

J Alzheimers Dis. 2019;69(3):651-661. doi: 10.3233/JAD-180780.

Online information and support for carers of people with young-onset dementia: A multi-site randomised controlled pilot study

Metcalfe A, Jones B, Mayer J, Gage H, Oyebode J, Boucault S, Aloui S, Schwertel U, Böhm M, Tezenas du Montcel S, Lebbah S, De Mendonça A, De Vugt M, Graff C, Jansen S, Hergueta T, Dubois B, Kurz A.

Int J Geriatr Psychiatry. 2019 Oct;34(10):1455-1464. doi: 10.1002/gps.5154. Epub 2019 Jul 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias